Summary
GlobalData's clinical trial report, “Xerosis (Dry Skin) Global Clinical Trials Review, H2, 2016" provides an overview of Xerosis (Dry Skin) clinical trials scenario. This report provides top line data relating to the clinical trials on Xerosis (Dry Skin). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.
The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.
*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months
*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Reasons to buy
- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level
*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Companies Mentioned
Laboratoires Pierre Fabre SA
Orfagen
L'Oreal S.A.
Johnson & Johnson
Dermal Laboratories Limited
CG Bio Inc.
Avvaa World Health Care Products, Inc.
Arbonne International, LLC
Amryt Pharma plc
ALK-Abello A/S
'
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
Report Guidance 4
Clinical Trials by Region 5
Clinical Trials and Average Enrollment by Country 6
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 8
Top Five Countries Contributing to Clinical Trials in Europe 9
Top Countries Contributing to Clinical Trials in North America 10
Clinical Trials by G7 Countries: Proportion of Xerosis (Dry Skin) to Dermatology Clinical Trials 11
Clinical Trials by Phase in G7 Countries 12
Clinical Trials in G7 Countries by Trial Status 13
Clinical Trials by E7 Countries: Proportion of Xerosis (Dry Skin) to Dermatology Clinical Trials 14
Clinical Trials by Phase 15
Clinical Trials by Trial Status 16
Clinical Trials by End Point Status 17
Subjects Recruited Over a Period of Time 18
Clinical Trials by Sponsor Type 19
Prominent Sponsors 20
Top Companies Participating in Xerosis (Dry Skin) Therapeutics Clinical Trials 21
Prominent Drugs 22
Clinical Trial Profile Snapshots 23
Appendix 41
Abbreviations 41
Definitions 41
Research Methodology 42
Secondary Research 42
About GlobalData 43
Contact Us 43
Disclaimer 43
Source 44
List of Tables
Xerosis (Dry Skin) Therapeutics, Global, Clinical Trials by Region, 2016* 5
Xerosis (Dry Skin) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 6
Xerosis (Dry Skin) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 7
Xerosis (Dry Skin) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2016* 8
Xerosis (Dry Skin) Therapeutics Clinical Trials, Europe, Top Five Countries, 2016* 9
Xerosis (Dry Skin) Therapeutics Clinical Trials, North America, Top Countries, 2016* 10
Proportion of Xerosis (Dry Skin) to Dermatology Clinical Trials, G7 Countries (%), 2016* 11
Xerosis (Dry Skin) Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 12
Xerosis (Dry Skin) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 13
Proportion of Xerosis (Dry Skin) to Dermatology Clinical Trials, E7 Countries (%), 2016* 14
Xerosis (Dry Skin) Therapeutics, Global, Clinical Trials by Phase, 2016* 15
Xerosis (Dry Skin) Therapeutics, Global, Clinical Trials by Trial Status, 2016* 16
Xerosis (Dry Skin) Therapeutics Clinical Trials, Global, by End Point Status, 2016* 17
Xerosis (Dry Skin) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 18
Xerosis (Dry Skin) Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2016* 19
Xerosis (Dry Skin) Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 20
Xerosis (Dry Skin) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 21
Xerosis (Dry Skin) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 22
List of Figures
Xerosis (Dry Skin) Therapeutics, Global, Clinical Trials by Region (%), 2016* 5
Xerosis (Dry Skin) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 6
Xerosis (Dry Skin) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 7
Xerosis (Dry Skin) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2016* 8
Xerosis (Dry Skin) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2016* 9
Xerosis (Dry Skin) Therapeutics Clinical Trials, North America, Top Countries (%), 2016* 10
Proportion of Xerosis (Dry Skin) to Dermatology Clinical Trials, G7 Countries (%), 2016* 11
Xerosis (Dry Skin) Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 12
Xerosis (Dry Skin) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 13
Proportion of Xerosis (Dry Skin) to Dermatology Clinical Trials, E7 Countries (%), 2016* 14
Xerosis (Dry Skin) Therapeutics, Global, Clinical Trials by Phase (%), 2016* 15
Xerosis (Dry Skin) Therapeutics, Global, Clinical Trials by Trial Status, 2016* 16
Xerosis (Dry Skin) Therapeutics Clinical Trials, Global, by End Point Status, 2016* 17
Xerosis (Dry Skin) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 18
Xerosis (Dry Skin) Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2016* 19
Xerosis (Dry Skin) Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 20
Xerosis (Dry Skin) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 21
Xerosis (Dry Skin) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 22
GlobalData Methodology 42
